Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Information Update - Update: Pharmascience Inc. recalls 30 lots of 150 mg over-the-counter ranitidine in blister packs


OTTAWA, ON, March 11, 2022 /CNW/ - Pharmascience Inc. is recalling 30 lots of over-the-counter ranitidine drugs (150 mg tablets) packaged in blister packs, after tests found NDMA, a nitrosamine impurity, above the acceptable level in some lots. NDMA is classified as a probable human carcinogen, which means long-term exposure to levels above what is considered safe could increase the risk of cancer. The products are sold under various private labels. Please refer to the Affected Products table for detailed information on the recalled lots.

Health Canada maintains a list of ranitidine drugs affected by this issue. Please see the full advisory for more information, including what consumers should do.

Affected Products

Product  Name

DIN

Strength

Lot

ATOMA maximum strength acid reducer without
prescription (24 tablets)

02293471

 

150 mg

629744F

ATOMA maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

632058H

Compliments maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

632043B

Compliments maximum strength acid reducer without
prescription cool mint (24 tablets)

02293471

150 mg

629973A

CO-OP Care+ maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

629744C

Health One maximum strength acid reducer without
prescription (32 tablets)

02293471

150 mg

629744J

Health One maximum strength acid reducer without
prescription (32 tablets)

02293471

150 mg

632043H

Life Brand maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

629744H

Life Brand maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

632058I

Life Brand maximum strength acid reducer without
prescription cool mint (48 tablets)

02293471

150 mg

629974B

Life Brand maximum strength acid reducer without
prescription cool mint (24 tablets)

02293471

150 mg

629974A

Option+ maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

629744G

Option+ maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

632043D

Option+ maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

632043E

Option+ maximum strength acid reducer without
prescription (8 tablets)

02293471

150 mg

632058A

Option+ maximum strength acid reducer without
prescription cool mint (24 tablets)

02293471

150 mg

629973B

Option+ maximum strength acid reducer without
prescription cool mint (24 tablets)

02293471

150 mg

631893C

PERSONNELLE maximum strength acid reducer
without prescription (24 tablets)

02293471

150 mg

629744E

PERSONNELLE maximum strength acid reducer
without prescription (24 tablets)

02293471

150 mg

632043A

PERSONNELLE maximum strength acid reducer
without prescription (24 tablets)

02293471

150 mg

632043F

PERSONNELLE maximum strength acid reducer
without prescription (24 tablets)

02293471

150 mg

632058J

PERSONNELLE maximum strength acid reducer
without prescription (8 tablets)

02293471

150 mg

629744B

PERSONNELLE maximum strength acid reducer
without prescription (8 tablets)

02293471

150 mg

632058B

PERSONNELLE maximum strength acid reducer
without prescription cool mint (24 tablets)

02293471

150 mg

629973C

PERSONNELLE maximum strength acid reducer
without prescription cool mint (48 tablets)

02293471

150 mg

629973D

PHARMASAVE maximum strength acid reducer without
prescription (8 tablets)

02293471

150 mg

629744A

Rexall maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

629744I

Rexall maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

632043G

Rexall maximum strength acid reducer without
prescription (24 tablets)

02293471

150 mg

632058G

Rexall maximum strength acid reducer without
prescription (8 tablets)

02293471

150 mg

632058D

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 07:35
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced it will conduct a Type B End-of-Phase 2 (EOP2) meeting in July with the U.S. Food and Drug Administration (FDA) to...

at 07:35
Zai Lab Announces Participation in May and June Investor Conferences
Zai Lab Limited today announced that members of the Company's senior management team will participate in the following investor conferences in May and June 2024: J.P. Morgan 20th Annual Global China Summit Panel Discussion: Thursday, May 23, 2024,...

at 07:35
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
Johnson & Johnson announced today that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with...

at 07:35
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
Biogen Inc. and Ionis Pharmaceuticals, Inc. ...

at 07:31
Metabolon Secures $60 Million Credit Facility to Drive Growth and Innovation
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announced that it has closed on a new $60 million...

at 07:30
HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot
HEAWELL AI's Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease ("CKD") progression when paired with Electronic Health Record ("EHR") linked...

More news about Health...


News published on and distributed by: